Clinical Trial Update: Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vaginal isonicotinic acid hydrazide administration prior to intrauterine device insertion completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Device Complications

Drugs mentioned

• Isonicotinic acid hydrazide (isonicotinic acid hydrazide)

Snippet

Sponsor: Aswan University Hospital | Conditions: IUCD Complication | Phase 4 | Status: COMPLETED